TIMOTHY OLIVE: Open Payments
NPI 1033418439 · POTEAU, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 13 payments from 11 companies in 2025. Trend: 2023 $450 · 2024 $560 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
Products named: REXULTI, MOUNJARO, TRELEGY ELLIPTA, GEMTESA, FANAPT, Dexcom G6 Transmitter, Wegovy, Kerendia.
Industry payments across OK — which companies pay providers there.
